Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…
The findings of a new research may inform strategies for treating intestinal diseases by targeting pathogens without killing beneficial gut bacteria.
Researchers at Harvard Medical School propose to “rejuvenate” a person’s microbiota by collecting stool samples for future treatment of diseases that could be managed with fecal microbial transplantation (FMT).
The findings of a recent study suggest that the production of inositol lipids is common in Bacteroidetes and other gut-associated bacteria, and it may be a means of cross-kingdom communication.
The findings of a recent study suggest that dengue and Zika viruses are able to change their host’s odor by altering the skin microbiota.
New research offers insights into how human gut bacteria recognize sulfated glycans. The findings could help to develop interventions for diseases where sulfated glycan metabolism is altered.
New research shows that microbiota diversity appears early in infants from nonindustrial populations and could be traced back to their mothers as well as to the local environment.
The findings of a small clinical trial suggest that probiotic treatment could be used in combination with antidepressant medication to treat clinical depression.
The findings of a new research suggest that IgG in breast milk promotes immunity against intestinal pathogens and shapes the development of the gut microbiota and immune cells in early…
The findings of a new research reveal the microbiota alterations during NAFLD and suggest that gut microbes can be used as an early clinical sign of the condition.
